Intended for healthcare professionals

  1. Research
  2. Re-evaluating cost...
  3. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
CCBYNC Open access
Research

Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5725 (Published 09 October 2014) Cite this as: BMJ 2014;349:g5725

Data supplement

  • Data Supplement

    Files in this Data Supplement:

Related articles

See more

Cited by...

  • 'Be on the TEAM Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents
  • Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections
  • Enter B and W: two new meningococcal vaccine programmes launched
  • Vaccine evaluation: lessons from a meningococcal B vaccine
  • Do we need a new approach to making vaccine recommendations?
  • Potential long term vaccine benefits poorly translate in cost effectiveness modelling
  • Authors' reply to Rappuoli and colleagues, Black, and Glennie and colleagues
  • Winter is coming: vaccine negotiations should be concluded swiftly
  • Cost effectiveness has its place, but so does common sense
Back to top